NCT00002363View on ClinicalTrials.gov

The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Peptide Construction 3, Synthetic

Trial Locations (1)

02908

Brown Univ School of Medicine, Providence

Sponsors
All Listed Sponsors
lead

Columbia Research Laboratories

INDUSTRY

NCT00002363 - The Safety and Effectiveness of SPC3 in HIV-1 Infected Patients | Biotech Hunter | Biotech Hunter